| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 129.07▼ | 129.15▼ | 128.17▼ | 118.09▲ | 119.22▲ |
| MA10 | 129.43▼ | 129.22▼ | 127.19▲ | 118.67▲ | 108.10▲ |
| MA20 | 129.66▼ | 127.07▲ | 122.32▲ | 116.89▲ | 93.65▲ |
| MA50 | 129.01▼ | 119.92▲ | 116.66▲ | 103.55▲ | 42.79▲ |
| MA100 | 128.42▼ | 117.05▲ | 119.52▲ | 89.79▲ | 27.46▲ |
| MA200 | 123.12▲ | 119.10▲ | 112.39▲ | 48.36▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.246▼ | -0.536▼ | 0.533▲ | -0.435▼ | 1.395▲ |
| RSI | 35.143▼ | 53.786▲ | 60.049▲ | 65.800▲ | 81.316▲ |
| STOCH | 22.414 | 27.417 | 52.527 | 37.484 | 83.167▲ |
| WILL %R | -100.000▼ | -62.432 | -48.915 | -35.160 | -18.843▲ |
| CCI | -213.837▼ | -48.219 | 37.230 | 136.552▲ | 130.291▲ |
|
Wednesday, December 10, 2025 08:41 AM
Abivax stock skyrocketed in July after the company announced overwhelmingly positive topline results from its Phase 3 ABTECT-1 (Study 105) and ABTECT-2 (Study 106) eight-week induction trials for oral ...
|
|
Tuesday, December 09, 2025 02:45 PM
Abivax is preparing a regulatory submission in the U.S. in the second half of 2026, provided an ongoing maintenance trial also hits the mark. It will also target other indications for obefazimod, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/12/25 | 134.855 | 138.17 | 126.30 | 127.23 | 3,805,294 |
| 09/12/25 | 116.98 | 123.16 | 115.71 | 123.04 | 2,708,196 |
| 08/12/25 | 116.88 | 118.88 | 113.79 | 115.05 | 922,498 |
| 05/12/25 | 109.75 | 115.12 | 109.10 | 114.51 | 1,297,146 |
| 04/12/25 | 112.50 | 112.565 | 107.055 | 110.64 | 2,569,726 |
| 03/12/25 | 112.95 | 115.45 | 109.00 | 110.93 | 2,414,401 |
| 02/12/25 | 120.98 | 121.472 | 114.34 | 114.83 | 976,603 |
| 01/12/25 | 125.25 | 125.51 | 118.27 | 119.92 | 905,775 |
| 28/11/25 | 126.97 | 126.97 | 123.85 | 124.83 | 369,233 |
| 26/11/25 | 128.87 | 130.25 | 124.73 | 125.68 | 919,767 |
|
|
||||
|
|
||||
|
|